CARY, N.C. and NEW YORK, March 25, 2021 /PRNewswire/ — THREAD, an progressive know-how and repair supplier that permits decentralized scientific analysis, and Lokavant, a number one scientific trial intelligence firm, at this time introduced a partnership to deliver companies working decentralized scientific trials (DCTs) superior analytics and actionable insights. Collectively, sponsors obtain the distinctive skill to proactively benchmark trial operational efficiency towards a Lokavant information set of greater than 1,300 scientific trials, leading to elevated visibility into trial efficiency and KPIs that enhance outcomes and improve the designs of future DCTs.
readers can request further data on how the partnership works here.
“We’re excited to pair Lokavant’s unmatched trial insights with THREAD to offer the primary data-driven answer targeted on bettering the efficiency of decentralized scientific trials,” mentioned John Reites, CEO of THREAD. “This partnership represents THREAD’s dedication to offering differentiated worth, high quality and efficiency as we advance international decentralized scientific trial approaches by introducing actionable information.”
Lokavant Perception highlights components of scientific trial execution via Key Threat Indicators (KRIs) of examine well being throughout historic and ongoing scientific trials. This ensures that THREAD customers can dynamically evaluate trial efficiency towards combination and present trade requirements, optimizing examine planning and execution. Via this functionality, researchers achieve unprecedented transparency and a capability to make knowledgeable selections within the administration of DCTs using THREAD.
“Partnering with THREAD expands Lokavant’s skill to supply superior insights from various information sources for the widest vary of scientific trial sorts,” mentioned Stephanie Lee Griffin, Chief Enterprise Officer of Lokavant. “We’re excited that this partnership affords the trade unprecedented insights and visibility as DCT approaches proceed to be quickly adopted.”
Lokavant permits next-generation scientific trials via data-driven merchandise, together with Lokavant Perception, a scientific operations benchmarking instrument, and its flagship product, Lokavant Oversight, a tech-enabled risk-based monitoring answer. Backed by over 1,300 de-identified scientific trials, Lokavant Oversight aggregates and delivers real-time information from disparate trial information sources, predicts points throughout scientific improvement to mitigate trial dangers, and empowers monitoring groups by visualizing crucial examine information. Lokavant Perception empowers scientific groups to benchmark scientific trial efficiency and analyze important indicators of trial success and failure. For extra data, please go to www.lokavant.com.
THREAD is a number one supplier of a proprietary, decentralized analysis platform and suite of supporting providers utilized by biopharma, CROs and life science organizations to remotely seize information from individuals and websites throughout, in-between and in lieu of in-clinic visits. THREAD’s platform and supporting providers are serving to clients to shorten examine launch timelines, cut back examine budgets with Digital Visits, and convey research from the clinic to sufferers’ houses. THREAD offers key platform options corresponding to eConsent, eCOA/ePRO, sensors, reminders, and telehealth Digital Visits to assist distant information seize, hybrid digital research, and totally decentralized research in key therapeutic areas. In 2019, THREAD was acquired by strategic well being care traders Water Avenue Healthcare Companions and JLL Companions. Go to www.threadresearch.com to be taught extra.
Stephanie Lee Griffin
THREAD Analysis Contact